Abstract:
At least 2.2 billion individuals suffer from glaucoma, which is an
asymptomatic chronic eye illness leading to complete blindness. Increased intraocular
pressure is a clinical contributor to glaucoma; thus, to reduce intraocular pressure, ocular
hypotensive eye drops are most commonly used. Unlike oral medications, patients’
knowledge on self-administration can lead to a great prognosis. As a result, good
awareness, and support from healthcare professionals about eye drop instillation is crucial
to lead a quality life in glaucoma patients.